Ori Biotech has raised around £75 million to launch its cell and gene therapy manufacturing platform into the market. The Ori platform enables therapy developers, contract manufacturers and academic researchers to transition from pre-clinical process discovery through clinical trials to commercial scale.  The London company is also launching its Lightspeed Early Access Program, allowing select … Continue reading Ori Biotech raises £75m for cell and gene therapy platform